Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.

Taurine supplementation confers benefit for cramps in patients with chronic liver disease

06 Sep 2018

Oral supplementation with taurine is safe and effective in the management of muscle cramps in patients with chronic liver disease, yielding significant reductions in the frequency, duration and intensity of cramps, according to a study.

A total of 49 chronic liver disease patients who had 3 muscle cramp episodes were randomized to receive either taurine supplementation or placebo for 4 weeks then crossed to the alternative arm. Taurine was introduced in a stepped fashion to minimize any potential gastrointestinal side effects: one 500-mg capsule twice daily for 2 weeks and two 500-mg capsules twice daily for the remaining 2 weeks.

Primary outcomes of frequency, duration and intensity of muscle cramps were recorded by the patients themselves. Biochemical parameters, such as serum taurine and methionine levels, were measured at each time point.

Only 30 patients (mean age 54.7 years; 70 percent male) completed the study. Oral taurine resulted in increased serum taurine levels (p<0.001). No adverse side effects associated with supplementation were recorded.

Supplementation dosing of 2 g/day for 2 weeks led to significant reductions in cramp frequency (seven cramp episodes; p=0.03), duration (89 minutes; p=0.03) and severity (1.4 units on a Likert scale; p<0.004) compared with placebo.

The present data suggest that taurine be considered as a safe and effective intervention in the management of muscle cramps in patients with chronic liver disease, researchers said. A daily supplementation dosing of 2 g/day can be safely prescribed to alleviate the painful muscle cramps experienced by patients with cirrhosis.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 2 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.